Synthesis, in silico, in vitro and in vivo evaluation of novel thiophene[3,2-b]indole-based potential EZH2 modulators as anti-inflammatory agents
Bioorganic Chemistry · 2026-11 · 184 · 110698
DOI: 10.1016/j.bioorg.2026.110698 ↗Kurz gefasst
Fachartikel in der Zeitschrift Bioorganic Chemistry, 2026-11. Verfasst von Wen-Ping Jiang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan. Hauptthemen laut MEDLINE: Enhancer of Zeste Homolog 2 Protein, Thiophenes, Edema, Anti-Inflammatory Agents, Non-Steroidal. Die Arbeit nennt 39 Literaturangaben. Gefördert von: China Medical University.
Abstract (Originalsprache)
Enhancer of zeste homolog 2 (EZH2), the catalytic subunit of polycomb repressive complex 2 (PRC2), has an important role in epigenetic regulation of inflammatory responses. In this study, two thiophene[3,2-b]indole derivatives, 164 (4-benzyl-4H-thieno[3,2-b]indole-2-carboxylic ester) and 164 M (4-benzyl-4H-thieno[3,2-b]indole-2-carboxylic acid), were rationally designed, synthesized, and evaluated for EZH2-associated anti-inflammatory activity. Molecular docking using the EZH2 structure (PDB ID: 5IJ7) suggested plausible binding poses for both compounds within the inhibitor-binding region. A sulfur-π contact between the thiophene moiety and Tyr111 was also observed and may contribute to stabilization of the predicted binding mode. In 100-ns molecular dynamics simulations, both protein-ligand complexes remained stable over the analyzed trajectories. MM/GBSA calculations gave binding free energies of -21.45 ± 3.16 and - 19.83 ± 4.92 kcal·mol-1 for 164 and 164 M, respectively, indicating broadly comparable predicted binding energetics. Preliminary ADMET analysis identified generally acceptable drug-like characteristics together with properties requiring further optimization. In LPS-stimulated RAW264.7 macrophages, both compounds reduced EZH2 expression and suppressed IL-1β and IL-6 production without appreciable cytotoxicity, with 164 showing a stronger effect on EZH2 expression at 1 μM. In a carrageenan-induced paw edema model, both compounds attenuated paw swelling and reduced serum NO, TNF-α, IL-1β, and IL-6 levels. These effects were accompanied by improved histopathological features and reduced EZH2 immunoreactivity in paw tissues. Overall, 164 and 164 M exhibited anti-inflammatory activity in cellular and animal models, while the computational and expression data support a possible association with EZH2 modulation. Direct inhibition of EZH2 catalytic activity remains to be confirmed biochemically.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan.
- Department of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan; Department of Organic Chemistry, School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, 217 Hong Bang Street…
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, College of Chinese Medicine, China Medical University, Taichung 404, Taiwan; Department of Food Nutrition and Health Biotechnology, Asia Univ…
- Department of Chinese Pharmaceutical Sciences and Chinese Medicine Resources, College of Chinese Medicine, China Medical University, Taichung 404, Taiwan.
- Department of Organic Chemistry, School of Pharmacy, University of Medicine and Pharmacy at Ho Chi Minh City, 217 Hong Bang Street, Cho Lon District, Ho Chi Minh City 700000, Viet Nam.
- Department of Pharmacy, College of Pharmacy, China Medical University, Taichung, Taiwan; Drug Development Research Unit, Research Center for Traditional Chinese Medicine, China Medical University Hospital, Taichung, Tai…
Förderung
- China Medical University
Zitieren
APA
Jiang, W. P., Huynh, H. T., Huang, G. J., Chiang, Y. T., Lien, J. C., Nguyen, P. T. V., Le, Q. N. N., Zhang, T. W., Juang, S. H., Kuo, S. C., & Hsieh, M. T. (2026). Synthesis, in silico, in vitro and in vivo evaluation of novel thiophene[3,2-b]indole-based potential EZH2 modulators as anti-inflammatory agents. Bioorganic Chemistry, 184, 110698. https://doi.org/10.1016/j.bioorg.2026.110698
Vancouver
Jiang WP, Huynh HT, Huang GJ, Chiang YT, Lien JC, Nguyen PTV, et al. Synthesis, in silico, in vitro and in vivo evaluation of novel thiophene[3,2-b]indole-based potential EZH2 modulators as anti-inflammatory agents. Bioorganic Chemistry. 2026;184:110698. doi:10.1016/j.bioorg.2026.110698
BibTeX
@article{Jiang2026,
author = {Jiang, Wen-Ping and Huynh, Hoang-Thuc and Huang, Guan-Jhong and Chiang, Yi-Ting and Lien, Jin-Cherng and Nguyen, Phuong Thuy Viet and Le, Quynh Nguyen Nhu and Zhang, Ting-Wei and Juang, Shin-Hun and Kuo, Sheng-Chu and Hsieh, Min-Tsang},
title = {Synthesis, in silico, in vitro and in vivo evaluation of novel thiophene[3,2-b]indole-based potential EZH2 modulators as anti-inflammatory agents},
journal = {Bioorganic Chemistry},
year = {2026},
volume = {184},
pages = {110698},
doi = {10.1016/j.bioorg.2026.110698}
}
EUVIMED